Ignacio Martinez
General Partner at Flagship Pioneering
Greater Boston
Overview
Work Experience
General Partner
2013 - Current
Flagship Pioneering was founded to offer an alternative to existing methods of entrepreneurial innovation. The Flagship team conceives, resources, and builds life sciences companies that invent breakthrough technologies, each based on an original product platform, to transform health care and sustainability. Our unique model combines scientific creativity, technological ingenuity, systematic entrepreneurship, executive leadership, professional capital management, and a vast network of expertise into a single institution that produces first-in-category companies though an emergent, evolutionary methodology. We call this process pioneering. Over nearly two decades, this approach has enabled Flagship to originate and foster the development of around 100 science-based companies, resulting in more than $30 billion in aggregate value, thousands of patents, and a pipeline of more than 50 clinical development programs. Flagship has more than $10 billion in private capital raised and managed by the company.
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Co-Founder, Board Member, Founding President and CEO
2017
Invaio Sciences is a multi-platform technology company that unlocks the potential of the planet’s interdependent systems to address pressing agricultural, nutritional and environmental challenges. Founded by Flagship Pioneering in 2018, Invaio leverages discoveries from diverse fields including human therapeutics, agriculture, environmental science, machine learning, data sciences and advanced manufacturing. The company’s deep understanding of the physiology of insects and novel approach to managing insect populations in a more sustainable and precise way, promises to refine agricultural practices and reduce the need for pesticides globally. Invaio Sciences is dedicated to developing technology that’s mindful of beneficials, bad for pests, and safer for us all
Invaio Sciences is a technology company that is dedicated to solving pressing agriculture, nutrition, and environmental challenges.
Raised $138,900,000.00 from K2 HealthVentures.
Co-Founder, Chairman of the Board, Founding President and CEO
2014
CiBO Technologies is developing an industry-changing online platform to provide objective, scientifically-driven insights to drive efficiency in farmland markets. At CiBO Technologies, we combine science, data, and software to enable agriculture scaling with unbiased information and direct connections. CiBO delivers high value, objective insights around farmland and its potential, to bring transparency to the agriculture value chain. We are a world-class team of engineers, scientists, and business professionals with expertise across data science, computational modeling, software design, agronomy, and biology.
CIBO scales regenerative advanced platform technology that connects growers to incentives and enterprises to growers.
Raised $67,399,997.00 from Flagship Pioneering and Indigo by Telkom Indonesia.
Board Member
2023
We've pioneered remote, capillary whole blood collection with devices that are virtually painless and easy to use - at home or in clinical settings. Our devices produce high-quality blood samples at high volumes, making them ideal for decentralized clinical trials, wellness testing, and clinical-grade blood sampling.
YourBio Health optimizes the interface of diagnostic medicine and healthcare consumer by simplifying blood sampling and testing.
Raised $98,163,337.00 from Newpath Management and Flagship Pioneering.
Co-Founder, Executive Chairman, Founding CEO
2020
Co-Founder, Board member, Founding President and CEO
2019
Montai is unlocking the power of nature with digital technologies to treat and preempt chronic disease, improving health outcomes for as many people as possible.
Co-Founder, Chairman of the Board, Founding President and CEO
2018
Senda is founded on the insight that human and non-human cells coevolved to exchange molecules continually. Natural nanoparticles evolved to shuttle information biomolecules into human cells, displaying tropism, potency, and repeatability in their interactions. Senda is the first company to decode this natural programming language to unlock full programming to the cell.
Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.
Raised $309,000,000.00 from Alexandria Venture Investments, Samsung Life Science Fund, State of Michigan Retirement System, Stage 1 Ventures, Mayo Clinic, Qatar Investment Authority, Bluwave Capital, Longevity Vision Fund, Flagship Pioneering and Partners Investment.
Co-Founder, Board Member, Founding President and CEO
2016
Through a transformational plant breeding approach, we are creating a new horizon in agriculture that is more predictive, efficient, affordable, inclusive, and respectful of the environment.
Inari is a biotechnology company that aims to transform agriculture and its impact on society and the environment.
Raised $609,000,000.00 from Flagship Pioneering, Rokos Capital Management, State of Michigan Retirement System, Hanwha Impact Partners, Rivas Capital, NGS Super and CPP Investments.
Board Member
2013 - 2019
Novomer’s synthetic chemical technology allows traditional chemical feedstocks to be combined with carbon dioxide or carbon monoxide to cost effectively synthesize sustainable chemicals and materials for a wide variety of applications. The chemicals and materials contain up to 50% by weight low cost waste carbon dioxide (CO2) or carbon monoxide (CO) and, as a result, have a significantly reduced carbon and energy footprint and advantaged economics as compared to the materials they will replace. Not only do the materials and chemicals offset the use of petroleum derived feedstocks, they also sequester the CO2 and CO for the life of the product, mitigating global warming and climate change.
Novomer is a sustainable chemistry company developing high performance, environmentally responsible polymers and chemical intermediates.
Raised $46,400,000.00 from Saudi Aramco Energy Ventures.
Co-Founder and Board Member
2013 - 2019
Plants rely on a vast array of natural, beneficial microbes to support their health and productivity. The community of microbes living in and around a plant—its microbiome—works in harmony with the plant to provide life-sustaining benefits throughout the plant’s lifecycle. They help the plant absorb nutrients in the soil and bolster its resilience to environmental stresses. Inspired by insights from the human microbiome, Indigo started with the hypothesis that microbes living inside the plant (endosymbionts) are vital to their health. But we found that some of these important microbes were being reduced by modern agricultural practices. By using sophisticated genomic sequencing and computational bioinformatics, Indigo has assembled what we believe is the world’s largest database of genomic information from these microbes
Indigo is an agricultural technology company that focuses on improving sustainability and profitability in farming practices.
Raised $1,439,000,000.00 from State of Michigan Retirement System, Lingotto, Flagship Pioneering and Timon Capital.